Applied DNA Sciences (NASDAQ:APDN) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a research note issued to investors on Monday. The brokerage issued a hold rating on the technology company’s stock.

Separately, HC Wainwright cut their price target on Applied DNA Sciences from $40.00 to $30.00 and set a buy rating for the company in a research note on Friday, February 9th.

Applied DNA Sciences Stock Performance

Shares of Applied DNA Sciences stock opened at $3.85 on Monday. Applied DNA Sciences has a 52 week low of $3.70 and a 52 week high of $37.20. The stock has a 50 day moving average price of $8.98 and a two-hundred day moving average price of $12.75. The stock has a market capitalization of $3.27 million, a PE ratio of -0.36 and a beta of 0.07.

Applied DNA Sciences (NASDAQ:APDN) last released its quarterly earnings data on Thursday, February 8th. The technology company reported ($1.80) earnings per share for the quarter, beating analysts’ consensus estimates of ($6.20) by $4.40. The firm had revenue of $0.89 million for the quarter, compared to analyst estimates of $0.70 million. Applied DNA Sciences had a negative net margin of 80.14% and a negative return on equity of 159.93%. Research analysts forecast that Applied DNA Sciences will post -12.6 EPS for the current year.

Hedge Funds Weigh In On Applied DNA Sciences

An institutional investor recently bought a new position in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC purchased a new stake in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned approximately 0.72% of Applied DNA Sciences at the end of the most recent reporting period. Institutional investors own 22.22% of the company’s stock.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.